Efficacy of Shunthi-Lodhra Churna in the Management of Asrigdara (DUB)
Objectives: The most common bleeding disorders in women are described as Asrigdara in Ayurveda, characterized by Pradirana (excessive excretion) of Raja (menstrual blood). It can be correlated to ‘Dysfunctional Uterine Bleeding’ in modern medicine. In modern medicine hormonal therapy, anti-prostaglandins & anti-fibrinolytic agents have not proven their definitive efficacy in spite of high costs; their side effects have led to hormonal imbalances. Methods: In order to overcome the above abnormalities, we conducted a clinical trial for 90 days on 30 patients of age group 18-45 yrs. We administered Shunthi Churna (2 gms.) and Lodhra Churna (3gms) mixed with Sharkara (5 gms.) i.e. total (10gms) thrice daily with cold water, after food. Two observations were taken, 1st after 45 days of treatment and the 2nd one after completion of treatment on various parameters like amount and duration of blood loss, inter-menstrual period, passage of clots and pain during menstruation. Results: Based on the parameters studied, we observed 60% of patients improved moderately, 36.7% showed mild-improvement, 3.3% showed marked-improvement in different symptoms. The results are highly significant on most parameters. Conclusion: Drug formulation Shunthi Churna and Lodhra Churna with Sharkara, proved to be effective in treating most of the symptoms of Asrigdara..
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.